Schedule 13G ownership disclosure

PHARVARIS N V

Ordinary Shares, Euro 0.12 par value per share · CUSIP: N69605108

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Bain Capital Life Sciences Fund, L.P.

    Shares: 1,640,817 · Class: 2.5%

  • BCIP Life Sciences Associates, LP

    Shares: 167,950 · Class: 0.3%

  • Bain Capital Life Sciences Opportunities III, LP

    Shares: 993,314 · Class: 1.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-054799
Form type
SCHEDULE 13G/A
Filer
Bain Capital Life Sciences Fund, L.P.
CIK
CIK 1687968
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub